Acadia Healthcare (NASDAQ:ACHC) Change of Rating
Deutsche Bank lowered the shares of Acadia Healthcare (NASDAQ:ACHC) from a Buy rating to Hold rating in an analyst note issued to clients and investors on Wednesday morning. The financial company after the upgrade has $37.0 PT on company.
The company’s rating downgrade was most probably noticed by stock traders, as NASDAQ:ACHC is right now trading -1.28% lower at $44.12 as of 8:10 AM New York time. Acadia Healthcare’s stock is 0% over the last 200 days. It has underperformed the S&P500, which has surged 6.00% over the same time period.
According to data compiled by Thomson Reuters, Acadia Healthcare (NASDAQ:ACHC)’s stock is covered by 16 equity analysts across the Street, with 0 analysts giving it a Sell rating, 16 a Buy rating, while 1 consider it a Hold. The 12-month consensus target price for the stock is $79.19, which reflects an upside potential of 79.49% over the current price.
Philadelphia Financial Management Of San Francisco Llc had the most significant stake with ownership of 343,735 shares as of Q2 2015 for 3.76% of the US long stock exposure. Pennant Capital Management Llc is another bullish active investment manager who is possessing 2.01 million shares of Acadia Healthcare or 3.49% of their US long stock exposure. Moreover, Bain Capital Investors Llc have 3.08% of their US long stock exposure invested in the company for 3.45 million shares. The Maryland-based fund Rock Springs Capital Management Lp revealed it had purchased so far a stake worth about 2.87% of the active investment manager’s stock portfolio in Acadia Healthcare. The Quebec – Canada-based fund Sectoral Asset Management Inc is also positive about the stock, possessing 924,678 shares or 2.81% of their US long stock exposure.
Acadia Healthcare (NASDAQ:ACHC) Profile
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S.
Acadia Healthcare (NASDAQ:ACHC) traded down -1.28% on 25 October, hitting $44.12. A total of 24,051 shares of the company’s stock traded hands. This is down from average of 907,922 shares. Acadia Healthcare has a 52 week low of $32.54 and a 52 week high of $54.34. The company has a market cap of $3.88B and a P/E ratio of 569.66.
Get the latest Acadia Healthcare (NASDAQ:ACHC) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
The post Acadia Healthcare (NASDAQ:ACHC) was Decreased at Deutsche Bank from a Buy Rating to Hold Rating with $37.0 TP appeared first on Octafinance.